CELLUMED Files Payment Order of 14 Billion KRW Against Primecore... Financial Structure Improvement Expected if Recovered
CELLUMED has filed a payment order of 14 billion KRW (44.86% of equity, which is 31.2 billion KRW) against Primecore Co., Ltd. This legal action follows debt default, with the jurisdiction changed from Seoul Central District Court to Seoul Eastern District Court and interest terms modified.
The lawsuit was authorized by the board on May 15, 2026, and includes procedural costs of 4.53 million KRW. The move is seen as proactive legal response to recover outstanding receivables from Primecore.
If successful, the recovery of 14 billion KRW could significantly improve liquidity and financial structure, but litigation duration and outcome remain uncertain. Additionally, investors should consider the financial risk from the disclaimed audit opinion for the most recent fiscal year (2025).
[AI Comprehensive Analysis]This is a positive event reflecting CELLUMED's active debt recovery efforts, which could greatly improve financials if successful. However, given litigation uncertainty and the company's own financial weakness (audit disclaimer), the near-term stock impact may be limited.
KOSDAQ Filing Information
Filing: [Correction of Description] Filing of Lawsuits, etc. and Application (Claims of Specified Amount or More)